805 related articles for article (PubMed ID: 17572893)
1. Factor V Leiden and G20210A prothrombin mutations in patients with recurrent pregnancy loss: data from the southeast of Turkey.
Altintas A; Pasa S; Akdeniz N; Cil T; Yurt M; Ayyildiz O; Batun S; Isi H
Ann Hematol; 2007 Oct; 86(10):727-31. PubMed ID: 17572893
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of factor V G1691A (factor V-Leiden) and prothrombin G20210A gene mutations in a recurrent miscarriage population.
Finan RR; Tamim H; Ameen G; Sharida HE; Rashid M; Almawi WY
Am J Hematol; 2002 Dec; 71(4):300-5. PubMed ID: 12447960
[TBL] [Abstract][Full Text] [Related]
3. Association between adverse pregnancy outcomes and maternal factor V G1691A (Leiden) and prothrombin G20210A genotypes in women with a history of recurrent idiopathic miscarriages.
Mahjoub T; Mtiraoui N; Tamim H; Hizem S; Finan RR; Nsiri B; Almawi WY
Am J Hematol; 2005 Sep; 80(1):12-9. PubMed ID: 16138341
[TBL] [Abstract][Full Text] [Related]
4. [Prothrombotic gene mutations in women with recurrent abortions and intrauterine fetal death].
Santoro R; Iannaccaro P; Sottilotta G
Minerva Ginecol; 2005 Aug; 57(4):447-50. PubMed ID: 16170289
[TBL] [Abstract][Full Text] [Related]
5. Factor V Leiden G1691A and factor II G20210A point mutations and pregnancy in North-West of Iran.
Bagheri M; Rad IA; Nanbakhsh F
Arch Gynecol Obstet; 2011 Nov; 284(5):1311-5. PubMed ID: 21773779
[TBL] [Abstract][Full Text] [Related]
6. A prospective case-control study analyzes 12 thrombophilic gene mutations in Turkish couples with recurrent pregnancy loss.
Yenicesu GI; Cetin M; Ozdemir O; Cetin A; Ozen F; Yenicesu C; Yildiz C; Kocak N
Am J Reprod Immunol; 2010 Feb; 63(2):126-36. PubMed ID: 19906129
[TBL] [Abstract][Full Text] [Related]
7. [Genetic thrombophilic defects (Factor V Leiden, prothrombin G20210A, MTHFR C677T) in women with recurrent fetal loss].
Kovacheva K; Ivanov P; Konova E; Simeonova M; Komsa-Penkova R
Akush Ginekol (Sofiia); 2007; 46(7):10-6. PubMed ID: 18333414
[TBL] [Abstract][Full Text] [Related]
8. Molecular analysis of factor V Leiden, factor V Hong Kong, factor II G20210A, methylenetetrahydrofolate reductase C677T, and A1298C mutations related to Turkish thrombosis patients.
Dölek B; Eraslan S; Eroğlu S; Kesim BE; Ulutin T; Yalçiner A; Laleli YR; Gözükirmizi N
Clin Appl Thromb Hemost; 2007 Oct; 13(4):435-8. PubMed ID: 17911197
[TBL] [Abstract][Full Text] [Related]
9. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.
Aznar J; Vayá A; Estellés A; Mira Y; Seguí R; Villa P; Ferrando F; Falcó C; Corella D; España F
Haematologica; 2000 Dec; 85(12):1271-6. PubMed ID: 11114134
[TBL] [Abstract][Full Text] [Related]
10. Genetic prothrombotic risk factors in women with unexplained pregnancy loss.
Sottilotta G; Oriana V; Latella C; Luise F; Piromalli A; Ramirez F; Mammì C; Santoro R; Iannaccaro P; Muleo G; Lombardo VT
Thromb Res; 2006; 117(6):681-4. PubMed ID: 16014310
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of antiphospholipid antibodies, factor V G1691A (Leiden) and prothrombin G20210A mutations in early and late recurrent pregnancy loss.
Mtiraoui N; Borgi L; Hizem S; Nsiri B; Finan RR; Gris JC; Almawi WY; Mahjoub T
Eur J Obstet Gynecol Reprod Biol; 2005 Apr; 119(2):164-70. PubMed ID: 15808373
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for clinical manifestations in carriers of Factor V Leiden and prothrombin gene mutations.
DeSancho MT; Berlus N; Christos PJ; Rand J
Blood Coagul Fibrinolysis; 2010 Jan; 21(1):11-5. PubMed ID: 19474699
[TBL] [Abstract][Full Text] [Related]
13. Third trimester nonrecurrent fetal loss is associated with factor V Leiden and prothrombin gene mutations.
Karateke A; Haliloglu B; Gurbuz A
J Matern Fetal Neonatal Med; 2005 Nov; 18(5):299-304. PubMed ID: 16390788
[TBL] [Abstract][Full Text] [Related]
14. The impact of heterozygosity for the factor V Leiden and factor II G20210A mutations on the risk of thrombosis in Greek patients.
Hatzaki A; Anagnostopoulou E; Metaxa-Mariatou V; Melissinos C; Philalithis P; Iliadis K; Kontaxis A; Liberatos K; Pangratis N; Nasioulas G
Int Angiol; 2003 Mar; 22(1):79-82. PubMed ID: 12771861
[TBL] [Abstract][Full Text] [Related]
15. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium.
Gerhardt A; Scharf RE; Beckmann MW; Struve S; Bender HG; Pillny M; Sandmann W; Zotz RB
N Engl J Med; 2000 Feb; 342(6):374-80. PubMed ID: 10666427
[TBL] [Abstract][Full Text] [Related]
16. Risk of recurrent venous thrombosis in homozygous carriers and double heterozygous carriers of factor V Leiden and prothrombin G20210A.
Lijfering WM; Middeldorp S; Veeger NJ; Hamulyák K; Prins MH; Büller HR; van der Meer J
Circulation; 2010 Apr; 121(15):1706-12. PubMed ID: 20368522
[TBL] [Abstract][Full Text] [Related]
17. The frequency of factor V Leiden and concomitance of factor V Leiden with prothrombin G20210A mutation and methylene tetrahydrofolate reductase C677T gene mutation in healthy population of Denizli, Aegean region of Turkey.
Kabukcu S; Keskin N; Keskin A; Atalay E
Clin Appl Thromb Hemost; 2007 Apr; 13(2):166-71. PubMed ID: 17456626
[TBL] [Abstract][Full Text] [Related]
18. Combined thrombophilic mutations in women with unexplained recurrent miscarriage.
Sotiriadis A; Vartholomatos G; Pavlou M; Kolaitis N; Dova L; Stefos T; Paraskevaidis E; Kalantaridou SN
Am J Reprod Immunol; 2007 Feb; 57(2):133-41. PubMed ID: 17217367
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of thrombophilia in women with severe ovarian hyperstimulation syndrome and cost-effectiveness of screening.
Fábregues F; Tàssies D; Reverter JC; Carmona F; Ordinas A; Balasch J
Fertil Steril; 2004 Apr; 81(4):989-95. PubMed ID: 15066453
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of factor V Leiden and prothrombin G20210A mutation in a large French population selected for nonthrombotic history: geographical and age distribution.
Mazoyer E; Ripoll L; Gueguen R; Tiret L; Collet JP; dit Sollier CB; Roussi J; Drouet L;
Blood Coagul Fibrinolysis; 2009 Oct; 20(7):503-10. PubMed ID: 19730248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
